retatrutide and tirzepatide Difference between retatrutide: the complete comparison guide The Future of Weight Loss

The American Cancer Society and National Lymphedema Network recommend regular physical activity, including resistance training, which was previously discouraged but is now recognized as safe and beneficial

Retatrutide is an investigational triple agonist (GIP, GLP-1, glucagon) with no MHRA or EMA marketing authorisation and no publicly available room-temperature stability data

Human medicines in 2025 European Medicines Agency

Limited Long-term Data : While short- to medium-term data are compelling, the long-term safety and efficacy profile over decades of treatment remains incompletely characterized

Beinaglutide for weight management in Chinese individuals with overweight or obesity: A phase 3 randomized controlled clinical study